Treatment of Bipolar Depression With Pentoxifylline
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Growing theoretical and clinical evidence has suggested that pentoxifylline may have an
effect in improving depressive symptoms. Herein, we aim to evaluate the effect of
pentoxifylline in patients with bipolar depression over an 8-week trial.